These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20415805)
1. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Narongroeknawin P; Danila MI; Humphreys LG; Barasch A; Curtis JR Spec Care Dentist; 2010; 30(2):77-82. PubMed ID: 20415805 [TBL] [Abstract][Full Text] [Related]
2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [TBL] [Abstract][Full Text] [Related]
3. Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw. Barrow SY Int J Dent Hyg; 2008 Nov; 6(4):376-7. PubMed ID: 19138190 [No Abstract] [Full Text] [Related]
4. Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. Cheung A; Seeman E N Engl J Med; 2010 Dec; 363(25):2473-4. PubMed ID: 20950167 [No Abstract] [Full Text] [Related]
5. Teriparatide therapy for osteonecrosis of the jaw. Chtioui H; Lamine F; Daghfous R N Engl J Med; 2011 Mar; 364(11):1081-2; author reply 1082. PubMed ID: 21410382 [No Abstract] [Full Text] [Related]
6. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. Lo JC; O'Ryan FS; Gordon NP; Yang J; Hui RL; Martin D; Hutchinson M; Lathon PV; Sanchez G; Silver P; Chandra M; McCloskey CA; Staffa JA; Willy M; Selby JV; Go AS; J Oral Maxillofac Surg; 2010 Feb; 68(2):243-53. PubMed ID: 19772941 [TBL] [Abstract][Full Text] [Related]
7. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review. Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715 [TBL] [Abstract][Full Text] [Related]
8. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. Khan AA; Morrison A; Kendler DL; Rizzoli R; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL; Taguchi A; Tetradis S; Watts NB; Brandi ML; Peters E; Guise T; Eastell R; Cheung AM; Morin SN; Masri B; Cooper C; Morgan SL; Obermayer-Pietsch B; Langdahl BL; Dabagh RA; Davison KS; Sándor GK; Josse RG; Bhandari M; El Rabbany M; Pierroz DD; Sulimani R; Saunders DP; Brown JP; Compston J; J Clin Densitom; 2017; 20(1):8-24. PubMed ID: 27956123 [TBL] [Abstract][Full Text] [Related]
9. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. Harper RP; Fung E J Oral Maxillofac Surg; 2007 Mar; 65(3):573-80. PubMed ID: 17307613 [No Abstract] [Full Text] [Related]
10. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Hoefert S; Schmitz I; Tannapfel A; Eufinger H Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569 [TBL] [Abstract][Full Text] [Related]
11. Teriparatide for bone loss in the jaw. Grey A N Engl J Med; 2010 Dec; 363(25):2458-9. PubMed ID: 20950165 [No Abstract] [Full Text] [Related]
12. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. Kunchur R; Need A; Hughes T; Goss A J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200 [TBL] [Abstract][Full Text] [Related]
13. [Osteonecrosis of the jaw developing during bisphosphonate treatment]. Udvardy E; Redl P; Márton I Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302 [TBL] [Abstract][Full Text] [Related]
14. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study. Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490 [TBL] [Abstract][Full Text] [Related]
15. Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05). Taguchi A; Tanaka S; Ozaki T; Arai K; Mori S; Ohta H; Hagino H; Tanaka S; Shiraki M; Nakamura T; Soen S; J Bone Miner Metab; 2023 Nov; 41(6):854-864. PubMed ID: 37897672 [TBL] [Abstract][Full Text] [Related]
16. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model. Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800 [TBL] [Abstract][Full Text] [Related]
17. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw. Tsai KY; Huang CS; Huang GM; Yu CT J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569 [No Abstract] [Full Text] [Related]
18. Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report. Wang HL; Weber D; McCauley LK J Periodontol; 2007 Mar; 78(3):584-94. PubMed ID: 17335384 [TBL] [Abstract][Full Text] [Related]
19. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. Mavrokokki T; Cheng A; Stein B; Goss A J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates and osteonecrosis of the jaw: a retrospective study. Murad OM; Arora S; Farag AF; Guber HA Endocr Pract; 2007; 13(3):232-8. PubMed ID: 17599853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]